Fukushima; Keiko

Patent Applications and Registrations

Patent applications and USPTO patent grants for Fukushima; Keiko.The latest application filed is for "method for analyzing psa, and a method for distinguishing prostate cancer from prostatic hypertrophy using that method for analyzing psa".

Company Profile

2.10.13

Fukushima; Keiko - Kanagawa N/A JP
Fukushima; Keiko - Yokohama JP
Fukushima; Keiko - Yokohama-shi JP
Fukushima; Keiko - Nara-ken JP
Fukushima; Keiko - Saitama-ken JP
Fukushima; Keiko - Saitama JP
Fukushima; Keiko - Nara JP

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method for analyzing PSA and method for distinguishing prostate cancer from prostatic hypertrophy using that method for analyzing PSA Grant 10,866,240 - Yamashita , et al. December 15, 2	2020-12-15
Method for analyzing PSA, and a method for distinguishing prostate cancer from prostatic hypertrophy using that method for analyzing PSA Grant 10,196,694 - Yamashita , et al. Fe	2019-02-05
Method For Analyzing Psa, And A Method For Distinguishing Prostate Cancer From Prostatic Hypertrophy Using That Method For Analyzing Psa App 20160138118 - Yamashita; Katsuko ; et al.	2016-05-19
Method for analyzing PSA, and a method for distinguishing prostate cancer from prostatic hypertrophy using that method for analyzing PSA Grant 9,285,368 - Yamashita , et al. March 15, 2	2016-03-15
2-phenoxy- and 2-phenylsulfonamide derivatives with CCR3 antagonistic activity for the treatment of inflammatory or immunological disorders Grant 9,206,186 - Li , et al. December 8, 2	2015-12-08
2-Phenoxy- and 2-Phenylsulfonamide Derivatives with CCR3 Antagonistic Activity for the Treatment of Inflammatory or Immunological Disorders App 20140005176 - Li; Yingfu ; et al.	2014-01-02
Method For Detecting Gastric Cancer App 20130130276 - Yamashita; Katsuko ; et al.	2013-05-23
Method For Analyzing Mucin 1 Having Siaalpha2-8siaalpha2-3galbeta Glycans App 20130115612 - Yamashita; Katsuko ; et al.	2013-05-09
Method For Analyzing Psa, And A Method For Distinguishing Prostate Cancer From Prostatic Hypertrophy Using That Method For Analyzing Psa App 20120282612 - Yamashita; Katsuko ; et al.	2012-11-08
Arylsulfonamide derivatives for use as CCR3 antagonists in the treatment of inflammatory and immunological disorders Grant 8,242,118 - Li , et al. August 14, 2	2012-08-14
Method For Analyzing Psa And Method For Distinguishing Prostate Cancer From Prostatic Hypertrophy Using That Method For Analyzing Psa App 20110294141 - Yamashita; Katsuko ; et al.	2011-12-01
Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders Grant 7,700,586 - Li , et al. April 20, 2	2010-04-20
2-phenoxy- and 2-phenylsulfonamide derivatives with CCR3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders Grant 7,674,797 - Li , et al. March 9, 2	2010-03-09
2-Phenoxy- and 2-Phenylsulfonamide Derivatives with CCR3 Antagonistic Activity for the Treatment of Inflammatory or Immunological Disorders App 20090286771 - Li; Yingfu ; et al.	2009-11-19
Optically active pyridine derivative and a medicament containing the same App 20090054424 - Murata; Toshiki ; et al.	2009-02-26
Optically active pyridine derivative and a medicament containing the same Grant 7,375,103 - Murata , et al. May 20, 2	2008-05-20
2-Phenoxy- and 2-phenylsulfomamide derivatives with ccr3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders App 20070155725 - Li; Yingfu ; et al.	2007-07-05
Optically active pyridine derivative and a medicament containing the same App 20050215547 - Murata, Toshiki ; et al.	2005-09-29
Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders App 20050070582 - Li, Yingfu ; et al.	2005-03-31

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.